Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-039564

Chief Business Development Off sold 417 shares at $47.42 ($19,774)

  • Chief Business Development Off acquired 417 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Business Development Off

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-06-26 Exercise or conversion : show line 1 in the form +417 $6.32 $2,635 417 D
2020-06-26 Sale : show line 2 in the form −417 $47.42 $19,774 0 D
Open-market sales · 417 sh · avg $47.42 · $19,774

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-06-26 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −417 417 D
Loading xslF345X03/doc4.xml…